University of Utah treated a man who developed blood clotting after receiving Johnson & Johnson vaccine

The man is now recovering at home, health system said. The blood clotting is not an issue with Moderna and Pfizer vaccines.

(Mary Altaffer | AP) The Johnson & Johnson COVID-19 vaccine sits on a table in the Staten Island borough of New York, Thursday, April 8, 2021. The vaccine is produced by Janssen Pharmaceutical Companies, a subsidiary of Johnson & Johnson. University of Utah Health recently treated a man for blood clots he may have developed as a reaction to his immunization with the Johnson & Johnson vaccine, the health system announced Wednesday, May 5, 2021.

University of Utah treated a man who developed blood clotting after receiving Johnson & Johnson vaccine

The man is now recovering at home, health system said. The blood clotting is not an issue with Moderna and Pfizer vaccines.

MOST VIEWED

1

Visitors to Utah’s National Parks were asked to report anti-American signs. This is what they did instead.

2

Are Latter-day Saints Christian? The U.S. Defense Department doesn’t appear to think so.

3

A major transit gap isolates one of Utah’s fastest-growing places from the Wasatch Front. Here’s how that could change.

4

A late spring frost wiped out much of Utah’s tree fruit crop. Here’s what growers are selling instead.

5

‘Mormon Land’: Legendary poet Carol Lynn Pearson on how she loves ‘parts’ of the LDS Church — and ‘left’ others

Sponsored Story

Utah Artist Fellowship Program awards $90,000 to 18 artists